Delayed Prostate Cancer Therapy Salisbury MD

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

James Edward Martin, MD
(410) 749-1282
145 E Carroll St Ste A1
Salisbury, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Miami Sch Of Med, Miami Fl 33101
Graduation Year: 1973

Data Provided by:
Gail C.s. Anderson
(410) 860-9805
100 E Carroll St
Salisbury, MD
Specialty
Radiation Oncology

Data Provided by:
Panpit Klug
(410) 749-1282
145 E Carroll St
Salisbury, MD
Specialty
Hematology, Medical Oncology

Data Provided by:
Robert Lane Taylor
(410) 546-6400
100 E Carroll St
Salisbury, MD
Specialty
Hematology

Data Provided by:
Bennett W Yu
(410) 749-1282
145 E Carroll St
Salisbury, MD
Specialty
Hematology / Oncology

Data Provided by:
Cho Cho, MD
540 Riverside Dr
Salisbury, MD
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Inst Of Med I, Yangon, Myanmar
Graduation Year: 1985

Data Provided by:
Robert Louis Clinton, MD
145 E Carroll St
Salisbury, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Md Sch Of Med, Baltimore Md 21201
Graduation Year: 1985

Data Provided by:
Jennifer Jo Morgan, MD
(410) 546-5277
Salisbury, MD
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Howard Univ Coll Of Med, Washington Dc 20059
Graduation Year: 1998

Data Provided by:
David Eric Cowall, MD
(410) 749-1282
145 E Carroll St Ste A3
Salisbury, MD
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Oh State Univ Coll Of Med, Columbus Oh 43210
Graduation Year: 1973

Data Provided by:
Gail Carole Anderson, MD
(410) 341-0005
100 E Carroll St
Salisbury, MD
Specialties
Oncology (Cancer), Radiation Oncology, Diagnostic Radiology
Gender
Female
Education
Medical School: Tufts Univ Sch Of Med, Boston Ma 02111
Graduation Year: 1979
Hospital
Hospital: Peninsula Regional Med Center, Salisbury, Md

Data Provided by:
Data Provided by:

Delayed Prostate Cancer Therapy

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com